Hunan Fangsheng Pharmaceutical Co (SHSE:603998) YoY EPS Growth : 25.00% (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Hunan Fangsheng Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was 25.00%.

Hunan Fangsheng Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ¥0.20.

Hunan Fangsheng Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co YoY EPS Growth Chart

Hunan Fangsheng Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-16.67

6.67

312.50

-36.36

38.10

Hunan Fangsheng Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															6.67	60.00	150.00	-33.33	25.00

Hunan Fangsheng Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Hunan Fangsheng Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(0.58	-	0.42)	/	\| 0.42 \|
=	38.10 %

Hunan Fangsheng Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(0.2	-	0.16)	/	\| 0.16 \|
=	25.00 %

Hunan Fangsheng Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN

Website

http://www.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.

Executives

He Shi	senior management
Xiao Han Qing	senior management
Liu Xin He	senior management
Chen Bo	Director
Chen Ai Chun	Director
Li Zhi Heng	senior management
Zhou Wei En	senior management
Zhang Qing Hua	Director
Huang Min	Director
Zhou Xiao Li	senior management
Fang Jin Cheng	Director
Fang Chuan Long	Supervisors
Tan Yuan Ming	Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines